Sunday, October 11, 2026

Cracker Barrel Old Country Store, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

December 25, 2020

Cracker Barrel Old Country Store, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Big Lots, Inc.

6.9% sales growth and 61.92% return on equity

Big Lots, Inc., through its subsidiaries, operates as a retailer in the United States.

Big Lots, Inc.'s sales growth this year is anticipated to be 16.9% and a negative 7.3% for next year.

Year-on-year quarterly revenue growth grew by 18%, now sitting on 6.07B for the twelve trailing months.

Big Lots, Inc.'s sales growth for the next quarter is 6.9%. The company's growth estimates for the present quarter and the next is 25.1% and 4.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 61.92%.

Big Lots, Inc.'s Stock Yearly Top and Bottom Value

Big Lots, Inc.'s stock is valued at $44.63 at 07:22 EST, way under its 52-week high of $57.24 and way higher than its 52-week low of $10.13.

Big Lots, Inc.'s Moving Average

Big Lots, Inc.'s worth is below its 50-day moving average of $48.50 and under its 200-day moving average of $45.37.

2. Cracker Barrel Old Country Store, Inc.

34.7% sales growth and 15.86% return on equity

Cracker Barrel Old Country Store, Inc. develops and operates the Cracker Barrel Old Country Store concept in the United States.

Cracker Barrel Old Country Store, Inc.'s sales growth this year is expected to be 7.5% and 13.8% for next year.

Year-on-year quarterly revenue growth declined by 13.7%, now sitting on 2.42B for the twelve trailing months.

Cracker Barrel Old Country Store, Inc.'s sales growth is a negative 0% for the current quarter and 34.7% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 69% and 149.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.86%.

Cracker Barrel Old Country Store, Inc.'s Stock Yearly Top and Bottom Value

Cracker Barrel Old Country Store, Inc.'s stock is valued at $133.89 at 07:22 EST, way below its 52-week high of $170.10 and way higher than its 52-week low of $53.61.

Cracker Barrel Old Country Store, Inc.'s Moving Average

Cracker Barrel Old Country Store, Inc.'s worth is below its 50-day moving average of $134.22 and way higher than its 200-day moving average of $121.36.

3. Collegium Pharmaceutical, Inc.

11.5% sales growth and 13.69% return on equity

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes various products for patients suffering from pain.

Collegium Pharmaceutical, Inc.'s sales growth this year is anticipated to be 5.1% and 10.4% for next year.

Year-on-year quarterly revenue growth grew by 8.5%, now sitting on 307.95M for the twelve trailing months.

Collegium Pharmaceutical, Inc.'s sales growth for the next quarter is 11.5%. The company's growth estimates for the ongoing quarter and the next is 542.9% and 3900%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.69%.

Collegium Pharmaceutical, Inc.'s Stock Yearly Top and Bottom Value

Collegium Pharmaceutical, Inc.'s stock is valued at $18.65 at 07:22 EST, way under its 52-week high of $25.59 and way above its 52-week low of $13.00.

Collegium Pharmaceutical, Inc.'s Moving Average

Collegium Pharmaceutical, Inc.'s value is below its 50-day moving average of $18.99 and below its 200-day moving average of $18.72.

4. InterDigital, Inc.

13.5% sales growth and 6.57% return on equity

InterDigital, Inc. designs and develops technologies that enable and enhance wireless communications in the United States and internationally.

InterDigital, Inc.'s sales growth this year is anticipated to be 11.5% and 0.8% for next year.

Year-on-year quarterly revenue growth grew by 20.6%, now sitting on 370.36M for the twelve trailing months.

InterDigital, Inc.'s sales growth for the next quarter is 13.5%. The company's growth estimates for the present quarter and the next is a negative 52.3% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.57%.

InterDigital, Inc.'s Stock Yearly Top and Bottom Value

InterDigital, Inc.'s stock is valued at $61.98 at 07:22 EST, below its 52-week high of $67.06 and way above its 52-week low of $31.04.

InterDigital, Inc.'s Moving Average

InterDigital, Inc.'s worth is above its 50-day moving average of $60.60 and above its 200-day moving average of $59.44.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,369 source documents archived
Query this data → isubstrate.com